EX-99.1 2 ea158948ex99-1_jasperthera.htm JASPER THERAPEUTICS, INC. PRESENTATION (PRELIMINARY DATA FROM A PHASE 1 STUDY OF JSP191, AN ANTI-CD117 MONOCLONAL ANTIBODY, IN COMBINATION WITH LOW DOSE IRRADIATION AND FLUDARABINE CONDITIONING:

Exhibit 99.1